{
    "medicine_id": "7f56ffbc08cb04f3366b228d0cd40c2acdda0c0e",
    "platform_id": "DB05173",
    "metadata": {
        "name": "Pretomanid 200 mg 1 Tablet",
        "composition": "200 mg 1 PTC299",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in cancer tumors unspecified and solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "PTC299 demonstrated a broad range of activity in blocking VEGF synthesis in multiple tumor types including breast cervical colorectal fibrosarcoma gastric lung melanoma neuroblastoma ovarian pancreatic prostate and renal cell cancer lines PTC299 as a monotherapy significantly reduced VEGF concentrations in tumors and plasma reduced tumor blood vessel density and substantially impeded tumor progression",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}